Filter
2460
Text search:
adverse
events
Featured
Recommendations
292
New Publications
588
Language
Document type
No document type
1227
Guidelines
440
Studies & Reports
408
Manuals
176
Strategic & Response Plan
83
Fact sheets
49
Training Material
45
Situation Updates
13
Infographics
5
Resource Platforms
4
Online Courses
4
Brochures
3
Videos
2
Countries / Regions
Global
103
India
102
South Africa
59
Western and Central Europe
54
Kenya
48
Ethiopia
44
Africa
36
Latin America and the Carribbean
34
Uganda
32
Ghana
31
Nepal
31
Tanzania
30
Nigeria
28
Zambia
27
Bangladesh
26
Philippines
24
Myanmar / Burma
23
Sierra Leone
22
Ukraine
21
Eastern Europe
20
Malawi
19
Liberia
18
South–East Asia Region
18
Cambodia
17
Rwanda
17
Namibia
16
Syria
13
Brazil
11
USA
10
Zimbabwe
10
South Sudan
10
Colombia
10
Guinea
9
Senegal
9
Asia
9
Mozambique
8
Lesotho
8
East and Southern Africa
8
Congo, Democratic Republic of
7
Germany
7
Indonesia
7
Eastern Europe and Central Asia
7
Eswatini/ Swaziland
6
Chile
6
Russia
6
Pakistan
5
Afghanistan
5
Thailand
5
West and Central Africa
5
Middle East and North Africa
5
Western Pacific Region
5
Venezuela
5
Cameroon
4
Haiti
4
Ecuador
4
Botswana
4
Yemen
4
Burkina Faso
3
Mali
3
Somalia
3
Jordan
3
Lebanon
3
China
3
Sudan
3
Sri Lanka
3
Paraguay
3
Palestine
3
Laos
3
Moldova
3
North America
3
Niger
2
Egypt
2
Chad
2
Central African Republic
2
Argentina
2
North Macedonia
2
El Salvador
2
Angola
2
Madagascar
2
Other region
2
Timor Leste/ East Timor
2
Kyrgyzstan
2
Vietnam
2
Belarus
2
Guinea-Bissau
1
Iraq
1
Gambia
1
Mauritania
1
Ireland
1
Peru
1
Burundi
1
Honduras
1
Bolivia
1
Bhutan
1
Poland
1
Albania
1
Djibouti
1
Canada
1
Tajikistan
1
Romania
1
Lithuania
1
Iran
1
Australia
1
Kazakhstan
1
Georgia
1
Turkmenistan
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
707
Clinical Guidelines
292
Key Resources
158
Public Health
141
Women & Child Health
129
Capacity Building
44
Pharmacy & Technologies
18
Toolboxes
Mental Health
282
COVID-19
212
HIV
179
TB
154
Planetary Health
143
NTDs
77
Caregiver
76
Pharmacy
67
AMR
59
NCDs
57
Ebola & Marburg
52
Conflict
50
Global Health Education
47
Rapid Response
46
Disability
36
Refugee
36
Malaria
35
2.0 Rapid Response
32
Natural Hazards
29
Specific Hazards
26
Polio
14
Zika
14
Health Financing Toolbox
14
Cholera
8
Social Ethics
4
Typhoon
1
In 1997, the Fiftieth World Health Assembly adopted resolution WHA50.29 on the elimination of
lymphatic filariasis as a public health problem. Preliminary guidance from WHO printed in 2011 referred to “verification” as the official process by which the achievements of the Global Programme to El
...
sthma prevalence is increasing worldwide, and surveys indicate that most patients in developed and developing countries, including South Africa, do not receive optimal care and are therefore not well controlled. Standard management guidelines adapted to in-country realities are important to support
...
Updated Guidelines
Clinical Infectious Diseases 2010; 50:291–322
Other disorders
Chapter H.5.1
Q2: In individuals with psychotic disorders (including schizophrenia), is the use of two or more antipsychotic medications concurrently more effective and safer than the use of one antipsychotic only?
Advice on physical activity should be encouraged as part of treatment for adults with depressive episode/disorder with inactive lifestyles. In moderate and severe depression, this intervention should be considered as adjunct to antidepressants or brief structured psychological treatments.
Start Free Stay Free AIDS Free - 2020 report
recommended
This progress report reviews recent gains, new developments and remaining challenges as countries approach the 2020 targets of the Start Free Stay Free AIDS Free framework.
The recommendation in this document thus supersedes the previous WHO recommendation for the prevention of PPH as published in the 2012 guideline, WHO recommendations for the prevention and treatment of postpartum haemorrhage.
Evidence from a systematic review on antenatal zinc supplementation was evaluated as part of the World Health Organization (WHO) antenatal care (ANC) guideline development process in 2016, and the following recommendation on zinc supplementation was made: “Zinc supplementation for pregnant women i
...
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
22 April 2022, This document provides updated interim recommendations on the use of masks by health workers providing care to patients with suspected or confirmed COVID-19. This update is prompted by new evidence around mask use and COVID-19 transmission, as well as the emergence of variants of conc
...
The Strategic Plan of Action and Budget 2016-2025 for the elimination of onchocerciasisin countries was prepared based on the above dlrective for the consideration of IAF 18.The vision of the plan of action is to eliminate onchocerciasis in 80 percent of Africancountries. Implementation of the plan
...
Access to safe blood and blood products is recognized as one of the key requirements for delivery of modern health care in the journey towards health for all. The foundation of safe and sustainable blood supplies depends on the collection of blood from voluntary non-remunerated and low-risk donors.
...
The recommendations in this guideline are intended to inform development of national and subnational health policies, clinical protocols and programmatic guides. The target audience includes national and subnational public health policy-makers, implementers and managers of maternal, newborn and chil
...
This guideline provides global, evidence-informed recommendations on a number of specific issues related to the management of severe acute malnutrition in infants and children, including in the context of HIV.
The Guidelines for the Diagnosis, Treatment and Prevention of Leprosy provide state-of-the-art knowledge and evidence on leprosy diagnosis, treatment and prevention based on a public health approach in endemic countries. The target audience of this document includes policy-makers in leprosy or infec
...
2nd edition. These guidelines include several notable changes from the first edition. For cutaneous leishmaniasis, ketoconazole has been removed from the list of treatment options; the number of Leishmania species for which there is strong evidence for the efficacy of miltefosine has increased from
...
